• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关节炎支原体衍生的丝裂原与肽/II类主要组织相容性复合体抗原复合物的结晶及初步晶体学分析。

Crystallization and preliminary crystallographic analysis of Mycoplasma arthritidis-derived mitogen complexed with peptide/MHC class II antigen.

作者信息

Zhao Yiwei, Li Zhong, Drozd Sandra, Guo Yi, Stack Robert, Hauer Charles, Li Hongmin

机构信息

Wadsworth Center, New York State Department of Health, Empire State Plaza, PO Box 509, Albany, New York 12201-0509, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):353-6. doi: 10.1107/S090744490302763X. Epub 2004 Jan 23.

DOI:10.1107/S090744490302763X
PMID:14747723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3924564/
Abstract

Mycoplasma arthritidis-derived mitogen (MAM), a bacterial superantigen, has been crystallized in complex with its human receptor, major histocompatibility complex (MHC) class II antigen, by the hanging-drop vapor-diffusion method. Crystals were obtained under three conditions, with ammonium sulfate, phosphate salt and PEG 8000 as the precipitant. The crystals grown under these conditions all belong to space group I222, with the same unit-cell parameters: a = 137.4, b = 178.2, c = 179.6 A. Diffraction data were collected to 3.3 and 3.4 A resolution from crystals of native and selenomethionylated MAM-MHC complexes, respectively. Self- and cross-rotation function calculations suggest the presence of two complex molecules in the asymmetric unit, resulting in a V(M) of 4.0 and a solvent content of 69%. An interpretable electron-density map was produced using a combination of molecular replacement and SAD phasing.

摘要

关节炎支原体衍生丝裂原(MAM)是一种细菌超抗原,已通过悬滴气相扩散法与它的人类受体主要组织相容性复合体(MHC)II类抗原形成复合物并结晶。在三种条件下获得了晶体,分别以硫酸铵、磷酸盐和聚乙二醇8000作为沉淀剂。在这些条件下生长的晶体均属于空间群I222,具有相同的晶胞参数:a = 137.4,b = 178.2,c = 179.6 Å。分别从天然和硒代甲硫氨酸化的MAM-MHC复合物晶体收集到了分辨率为3.3 Å和3.4 Å的衍射数据。自身旋转函数和交叉旋转函数计算表明在不对称单元中存在两个复合物分子,V(M)为4.0,溶剂含量为69%。结合分子置换和单波长反常散射(SAD)相位法生成了可解释的电子密度图。

相似文献

1
Crystallization and preliminary crystallographic analysis of Mycoplasma arthritidis-derived mitogen complexed with peptide/MHC class II antigen.关节炎支原体衍生的丝裂原与肽/II类主要组织相容性复合体抗原复合物的结晶及初步晶体学分析。
Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):353-6. doi: 10.1107/S090744490302763X. Epub 2004 Jan 23.
2
Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex.与HLA - DR1复合的关节炎支原体丝裂原的晶体结构揭示了一种新型超抗原折叠和二聚化的超抗原 - 主要组织相容性复合体。
Structure. 2004 Feb;12(2):277-88. doi: 10.1016/j.str.2004.01.008.
3
A single point mutation changes the crystallization behavior of Mycoplasma arthritidis-derived mitogen.一个单点突变改变了关节炎支原体衍生丝裂原的结晶行为。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Mar 1;62(Pt 3):238-41. doi: 10.1107/S1744309106003691. Epub 2006 Feb 10.
4
Crystallization and preliminary X-ray analysis of Yersinia pseudotuberculosis-derived mitogen.假结核耶尔森氏菌衍生促细胞分裂剂的结晶及初步X射线分析
Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1330-2. doi: 10.1107/s0907444903010710. Epub 2003 Jun 27.
5
Crystal structure of the Mycoplasma arthritidis-derived mitogen in apo form reveals a 3D domain-swapped dimer.无辅基状态下的黏质沙雷氏菌来源丝裂原的晶体结构揭示了一种 3D 结构域交换二聚体。
J Mol Biol. 2010 Jun 11;399(3):367-76. doi: 10.1016/j.jmb.2010.04.030. Epub 2010 Apr 22.
6
Zinc-binding sites in the N terminus of Mycoplasma arthritidis-derived mitogen permit the dimer formation required for high affinity binding to HLA-DR and for T cell activation.关节炎支原体衍生的促细胞分裂剂N端的锌结合位点允许形成二聚体,这是与HLA-DR高亲和力结合及T细胞活化所必需的。
J Biol Chem. 2003 Jun 20;278(25):22309-15. doi: 10.1074/jbc.M300823200. Epub 2003 Apr 3.
7
Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.关节炎支原体衍生的超抗原在THP-1人单核细胞系中诱导促炎单核因子基因表达。
Infect Immun. 1994 Jun;62(6):2409-16. doi: 10.1128/iai.62.6.2409-2416.1994.
8
Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC.TCR、超抗原和肽-MHC完整三元复合物的晶体结构。
Nat Struct Mol Biol. 2007 Feb;14(2):169-71. doi: 10.1038/nsmb1193. Epub 2007 Jan 14.
9
Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen.锌可诱导II类主要组织相容性复合体分子发生二聚化,进而导致其与超抗原协同结合。
J Biol Chem. 2007 Mar 2;282(9):5991-6000. doi: 10.1074/jbc.M608482200. Epub 2006 Dec 13.
10
Binding of Mycoplasma arthritidis-derived mitogen to human MHC class II molecules via its N terminus is modulated by invariant chain expression and its C terminus is required for T cell activation.关节炎支原体衍生的丝裂原通过其N端与人MHC II类分子的结合受恒定链表达的调节,其C端是T细胞活化所必需的。
Eur J Immunol. 2000 Jun;30(6):1748-56. doi: 10.1002/1521-4141(200006)30:6<1748::AID-IMMU1748>3.0.CO;2-J.

引用本文的文献

1
Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.支原体的感染策略:揭开毒力因子的全貌。
Virulence. 2021 Dec;12(1):788-817. doi: 10.1080/21505594.2021.1889813.
2
Crystal structure of the Mycoplasma arthritidis-derived mitogen in apo form reveals a 3D domain-swapped dimer.无辅基状态下的黏质沙雷氏菌来源丝裂原的晶体结构揭示了一种 3D 结构域交换二聚体。
J Mol Biol. 2010 Jun 11;399(3):367-76. doi: 10.1016/j.jmb.2010.04.030. Epub 2010 Apr 22.
3
Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen.锌可诱导II类主要组织相容性复合体分子发生二聚化,进而导致其与超抗原协同结合。
J Biol Chem. 2007 Mar 2;282(9):5991-6000. doi: 10.1074/jbc.M608482200. Epub 2006 Dec 13.
4
Mutagenesis, biochemical, and biophysical characterization of Mycoplasma arthritidis-derived mitogen.关节炎支原体衍生促细胞分裂剂的诱变、生化及生物物理特性分析
Mol Immunol. 2007 Feb;44(5):763-73. doi: 10.1016/j.molimm.2006.04.010. Epub 2006 Jun 5.
5
A single point mutation changes the crystallization behavior of Mycoplasma arthritidis-derived mitogen.一个单点突变改变了关节炎支原体衍生丝裂原的结晶行为。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Mar 1;62(Pt 3):238-41. doi: 10.1107/S1744309106003691. Epub 2006 Feb 10.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes.存在诸多阻碍方式:超抗原依赖性T细胞信号复合物分子结构的多样性。
Curr Opin Immunol. 2002 Feb;14(1):36-44. doi: 10.1016/s0952-7915(01)00296-5.
3
Maximum-likelihood density modification using pattern recognition of structural motifs.利用结构基序的模式识别进行最大似然密度修正
Acta Crystallogr D Biol Crystallogr. 2001 Dec;57(Pt 12):1755-62. doi: 10.1107/s0907444901013737. Epub 2001 Nov 21.
4
Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.α干扰素诱导的内源性超抗原。一个连接环境与自身免疫的模型。
Immunity. 2001 Oct;15(4):591-601. doi: 10.1016/s1074-7613(01)00212-6.
5
Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.爱泼斯坦-巴尔病毒激活编码超抗原的人类内源性逆转录病毒HERV-K18。
Immunity. 2001 Oct;15(4):579-89. doi: 10.1016/s1074-7613(01)00210-2.
6
Toxic shock syndrome and bacterial superantigens: an update.中毒性休克综合征与细菌超抗原:最新进展
Annu Rev Microbiol. 2001;55:77-104. doi: 10.1146/annurev.micro.55.1.77.
7
Structural evidence for the evolution of pyrogenic toxin superantigens.致热毒素超抗原进化的结构证据。
J Mol Evol. 2000 Dec;51(6):520-31. doi: 10.1007/s002390010116.
8
Microbial superantigens: from structure to function.微生物超抗原:从结构到功能
Trends Microbiol. 2000 Aug;8(8):369-75. doi: 10.1016/s0966-842x(00)01793-5.
9
Binding of Mycoplasma arthritidis-derived mitogen to human MHC class II molecules via its N terminus is modulated by invariant chain expression and its C terminus is required for T cell activation.关节炎支原体衍生的丝裂原通过其N端与人MHC II类分子的结合受恒定链表达的调节,其C端是T细胞活化所必需的。
Eur J Immunol. 2000 Jun;30(6):1748-56. doi: 10.1002/1521-4141(200006)30:6<1748::AID-IMMU1748>3.0.CO;2-J.
10
Superantigens - powerful modifiers of the immune system.超抗原——免疫系统的强力调节剂。
Mol Med Today. 2000 Mar;6(3):125-32. doi: 10.1016/s1357-4310(99)01657-3.